File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Emergency aortic stent-graft treatment in patients with malignant aorto-esophageal fistula is worthwhile

TitleEmergency aortic stent-graft treatment in patients with malignant aorto-esophageal fistula is worthwhile
Authors
Issue Date2017
PublisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/ASH
Citation
The Royal College of Surgeons of Edinburgh and College of Surgeons of Hong Kong (RCSEd/CSHK) Conjoint Scientific Congress 2017: Controversies in Surgery, Hong Kong, 23-24 September 2017. In Surgical Practice, 2017, v. 21 n. Suppl. 1, p. 33-34, abstract no. P45 How to Cite?
AbstractAim: To investigate the outcome of emergency aorticstent-graft treatment in patients with malignant aorto-esophageal fistula (AEF). Methods: Two patients with advanced squamous cellcarcinoma of the mid-esophagus were reported.Both patients had esophageal stents in-situ anddeveloped sudden onset massive haematemesis and haemodynamic instability due to primary AEF. Anelectronic search was performed to identify similar published case reports. A case series was con-structed with comparison on the patient’s demographics, tumour status, operation performed,clinical outcome and survival. Results: Six patients with malignant AEF werereported in this series. Hemostas is was successfully achieved with endovascular aortic stent-graft in allpatients. On average, the patients survived for morethan three months after the operation with no furtherseptic or haemorrhagic complications. Five out of sixpatients finally passed away due to terminal malig-nancy while one patient survived with good recovery. Conclusion: We emphasize that even when theesophageal tumours are locally advanced, TEVAR(Thoracic endovascular aortic stent-graft repair) should be regarded as the first line treatment of AEFas supported by its relatively low operative mortality and effective control of massive hematemesis. A rea-sonable prolongation of survival could be achieved even in patients with malignant AEF.
DescriptionPoster Presentation
Persistent Identifierhttp://hdl.handle.net/10722/253600
ISSN
2013 Impact Factor: 0.172
2015 SCImago Journal Rankings: 0.121

 

DC FieldValueLanguage
dc.contributor.authorWong, PC-
dc.contributor.authorChan, YC-
dc.contributor.authorLaw, Y-
dc.contributor.authorCheng, SWK-
dc.date.accessioned2018-05-21T03:00:13Z-
dc.date.available2018-05-21T03:00:13Z-
dc.date.issued2017-
dc.identifier.citationThe Royal College of Surgeons of Edinburgh and College of Surgeons of Hong Kong (RCSEd/CSHK) Conjoint Scientific Congress 2017: Controversies in Surgery, Hong Kong, 23-24 September 2017. In Surgical Practice, 2017, v. 21 n. Suppl. 1, p. 33-34, abstract no. P45-
dc.identifier.issn1744-1625-
dc.identifier.urihttp://hdl.handle.net/10722/253600-
dc.descriptionPoster Presentation-
dc.description.abstractAim: To investigate the outcome of emergency aorticstent-graft treatment in patients with malignant aorto-esophageal fistula (AEF). Methods: Two patients with advanced squamous cellcarcinoma of the mid-esophagus were reported.Both patients had esophageal stents in-situ anddeveloped sudden onset massive haematemesis and haemodynamic instability due to primary AEF. Anelectronic search was performed to identify similar published case reports. A case series was con-structed with comparison on the patient’s demographics, tumour status, operation performed,clinical outcome and survival. Results: Six patients with malignant AEF werereported in this series. Hemostas is was successfully achieved with endovascular aortic stent-graft in allpatients. On average, the patients survived for morethan three months after the operation with no furtherseptic or haemorrhagic complications. Five out of sixpatients finally passed away due to terminal malig-nancy while one patient survived with good recovery. Conclusion: We emphasize that even when theesophageal tumours are locally advanced, TEVAR(Thoracic endovascular aortic stent-graft repair) should be regarded as the first line treatment of AEFas supported by its relatively low operative mortality and effective control of massive hematemesis. A rea-sonable prolongation of survival could be achieved even in patients with malignant AEF.-
dc.languageeng-
dc.publisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/ASH-
dc.relation.ispartofSurgical Practice-
dc.relation.ispartofRCSEd/CSHK Conjoint Scientific Congress 2017-
dc.titleEmergency aortic stent-graft treatment in patients with malignant aorto-esophageal fistula is worthwhile-
dc.typeConference_Paper-
dc.identifier.emailChan, YC: ycchan88@hkucc.hku.hk-
dc.identifier.emailLaw, Y: ylaw@hku.hk-
dc.identifier.emailCheng, SWK: swkcheng@hku.hk-
dc.identifier.authorityChan, YC=rp00530-
dc.identifier.authorityCheng, SWK=rp00374-
dc.identifier.hkuros285005-
dc.identifier.volume21-
dc.identifier.issueSuppl. 1-
dc.identifier.spage33-
dc.identifier.epage34-
dc.publisher.placeAustralia-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats